ATE276272T1 - Entzündungshemmende peptide - Google Patents

Entzündungshemmende peptide

Info

Publication number
ATE276272T1
ATE276272T1 AT94921322T AT94921322T ATE276272T1 AT E276272 T1 ATE276272 T1 AT E276272T1 AT 94921322 T AT94921322 T AT 94921322T AT 94921322 T AT94921322 T AT 94921322T AT E276272 T1 ATE276272 T1 AT E276272T1
Authority
AT
Austria
Prior art keywords
peptides
inflammatory peptides
peptide
pharmaceutical compositions
methods
Prior art date
Application number
AT94921322T
Other languages
English (en)
Inventor
David F Counts
Ronald G Duff
Original Assignee
Curative Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curative Tech Inc filed Critical Curative Tech Inc
Application granted granted Critical
Publication of ATE276272T1 publication Critical patent/ATE276272T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94921322T 1993-06-18 1994-06-17 Entzündungshemmende peptide ATE276272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8037193A 1993-06-18 1993-06-18
PCT/US1994/006888 WO1995000543A1 (en) 1993-06-18 1994-06-17 Anti-inflammatory peptides

Publications (1)

Publication Number Publication Date
ATE276272T1 true ATE276272T1 (de) 2004-10-15

Family

ID=22156955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921322T ATE276272T1 (de) 1993-06-18 1994-06-17 Entzündungshemmende peptide

Country Status (7)

Country Link
EP (1) EP0714404B1 (de)
JP (1) JP3645905B2 (de)
AT (1) ATE276272T1 (de)
AU (1) AU7209594A (de)
CA (2) CA2568107C (de)
DE (1) DE69433999T2 (de)
WO (1) WO1995000543A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245457T3 (es) * 1995-07-10 2006-01-01 Asahi Medical Co., Ltd. Sistema de circulacion sanguinea extracorporal para el tratamiento de enfermedades inflamatorias.
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
KR20100057055A (ko) * 2007-09-11 2010-05-28 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 ｓｆｌｌｒ－ｏｈ 및 뮤라밀 디펩티드의 용도
EP2229951A1 (de) 2009-03-08 2010-09-22 Stichting Katholieke Universiteit Verfahren zur Behandlung oder Vorbeugung von systemischer Sklerose
CN112759634B (zh) * 2021-01-21 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构feyieenky的生物活性肽及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5480869A (en) * 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
WO1992011021A1 (en) * 1990-12-21 1992-07-09 Curative Technologies, Inc. Angiogenic peptides
US5482930A (en) * 1993-06-09 1996-01-09 The Regents Of The University Of California Anti-inflammatory composition and method with des-Tyr dynorphin and analogues

Also Published As

Publication number Publication date
EP0714404A4 (de) 1999-02-10
CA2165418C (en) 2007-03-13
EP0714404A1 (de) 1996-06-05
DE69433999D1 (de) 2004-10-21
AU7209594A (en) 1995-01-17
CA2568107C (en) 2011-06-14
CA2568107A1 (en) 1995-01-05
JP3645905B2 (ja) 2005-05-11
EP0714404B1 (de) 2004-09-15
DE69433999T2 (de) 2005-09-22
CA2165418A1 (en) 1994-12-19
JPH09501415A (ja) 1997-02-10
WO1995000543A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
ID17863A (id) Komposisi-komposisi farmasi yang terdiri dari siklosporin
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
SE9404115L (sv) Salter av peptider med karboxiterminerade polyestrar
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
ATE245977T1 (de) Therapeutische substituierte guanidine
NO980296L (no) Forbedrede terapeutiske midler
DE69433999D1 (de) Entzündungshemmende peptide
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9400072A (es) Agentes antiinflamatorios derivados de difluoropentapeptido.
IT7850967A0 (it) Composti peptidici derivati da glicina loro procedimento di produzione e composizioni farmaceutiche cheli contengono
IT1277338B1 (it) Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
IT1270976B (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono
ITMI922332A0 (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR1100310A (pt) Peptìdeo, composto e composição farmacêutica
ITMI930311A0 (it) Composizioni farmeceutiche di derivati amminoacidi
ITMI920368A0 (it) Composizioni farmaceutiche di derivati amminoacidi
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
ITMI931657A0 (it) Nove amidi di acidi biliari, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties